Join Medical Academic and Accord Healthcare for a webinar on treatment options for erectile dysfunction with subject expert Dr Jireh Serfontein. ED, often exacerbated with age and lifestyle behaviours, is a commonly-encountered condition in South African clinical practice. This webinar is accredited for 1 General CPD point and is proudly sponsored by Accord.
Erectile dysfunction (ED) is a common condition affecting up to 77% of men. Men with ED have a 50% higher risk of heart attacks and strokes (6%) compared to men without ED (3%). It is estimated that only 25% of men with ED receive treatment. Sexual function can affect quality of life and overall health. Many men with ED may experience depression or low self-esteem at some point, and ED can put strain on relationships.
Presented by
Conrad Strydom
Editor: Medical Academic
Dr Jireh Serfontein
Medical Doctor and Sexologist
Dr Jireh Serfontein is a medical doctor who has a special interest in sexual health and HIV management. She is the Clinical Head of the MSH Licensed Practice in Pretoria and serves as a Medical Sexologist on the Prostate Cancer Foundation’s Medical and Scientific Advisory Board. Dr Serfontein holds a Master’s Degree in Sexual Health from the University of Sydney. She is a highly qualified medical doctor and sexologist with over 10 years of experience in the field. Dr Serfontein is dedicated to providing the highest standard of medical care, focusing on a holistic approach to sexual health that takes into consideration the physical, mental and emotional health of patients.
New Media, a division of Media24 (PTY) Ltd., abides to all data and privacy requirements. To find out more about our Privacy Policy you can find it here: www.media24.com/group-privacy-portal.
Please Note: The names, surnames, email addresses and duration of attendance of all webinar participants will be shared for statistical purposes only, with the sponsor of this webinar. No delegate will be contacted by the sponsor with marketing or sales offers, and your information will not be shared with any third-parties.
Should you wish to receive further information on the webinar topic from our sponsor, please opt in above.
